MDxHealth SA (MDXH)
(Delayed Data from NSDQ)
$3.16 USD
+0.33 (11.66%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $3.18 +0.02 (0.63%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth C Momentum B VGM
Balance Sheet
Fiscal Year End for MDxHealth SA falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 22 | 16 | 59 | 16 | 22 |
Receivables | 11 | 9 | 5 | 4 | 7 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 3 | 2 | 2 | 2 | 1 |
Other Current Assets | 2 | 2 | 2 | 1 | 1 |
Total Current Assets | 38 | 29 | 67 | 23 | 31 |
Net Property & Equipment | 5 | 4 | 2 | 1 | 1 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 80 | 82 | 3 | 5 | 7 |
Deposits & Other Assets | 6 | 4 | 3 | 3 | 1 |
Total Assets | 129 | 119 | 75 | 32 | 41 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 9 | 10 | 7 | 5 | 5 |
Current Portion Long-Term Debt | 1 | 1 | 4 | 3 | 1 |
Current Portion Capital Leases | 1 | 1 | 1 | 1 | 1 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 9 | 6 | 4 | 4 | 4 |
Total Current Liabilities | 20 | 18 | 16 | 13 | 10 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 36 | 35 | 8 | 10 | 9 |
Non-Current Capital Leases | 4 | 3 | 3 | 2 | 1 |
Other Non-Current Liabilities | 63 | 54 | 1 | 1 | 1 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 122 | 110 | 28 | 26 | 21 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 174 | 133 | 128 | 77 | 63 |
Capital Surplus | 153 | 153 | 153 | 136 | 136 |
Retained Earnings | -331 | -288 | -244 | -215 | -187 |
Other Equity | 12 | 11 | 10 | 8 | 7 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 7 | 9 | 47 | 6 | 20 |
Total Liabilities & Shareholder's Equity | 129 | 119 | 75 | 32 | 41 |
Total Common Equity | 7 | 9 | 47 | 6 | 20 |
Shares Outstanding | 1.50 | 1.50 | 1.50 | 7.00 | 5.90 |
Book Value Per Share | 4.81 | 6.21 | 31.27 | 0.84 | 3.34 |
Fiscal Year End for MDxHealth SA falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | -99,985 | 22 | 33 | -99,960 |
Receivables | NA | 13 | 11 | 9 | 8 |
Notes Receivable | NA | NA | 0 | 0 | NA |
Inventories | NA | 3 | 3 | 3 | 3 |
Other Current Assets | NA | 2 | 2 | 1 | 1 |
Total Current Assets | NA | 32 | 38 | 46 | 52 |
Net Property & Equipment | NA | 5 | 5 | 5 | 5 |
Investments & Advances | NA | NA | 0 | 0 | NA |
Other Non-Current Assets | NA | NA | 0 | 0 | NA |
Deferred Charges | NA | NA | 0 | 0 | NA |
Intangibles | NA | 80 | 80 | 80 | 81 |
Deposits & Other Assets | NA | 5 | 6 | 5 | 5 |
Total Assets | NA | 122 | 129 | 136 | 143 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | 0 | 0 | NA |
Accounts Payable | NA | 9 | 9 | 9 | 11 |
Current Portion Long-Term Debt | NA | 1 | 1 | 1 | 1 |
Current Portion Capital Leases | NA | 2 | 1 | 1 | 1 |
Accrued Expenses | NA | NA | 0 | 0 | NA |
Income Taxes Payable | NA | NA | 0 | 0 | NA |
Other Current Liabilities | NA | 8 | 9 | 8 | 29 |
Total Current Liabilities | NA | 19 | 20 | 19 | 41 |
Mortgages | NA | NA | 0 | 0 | NA |
Deferred Taxes/Income | NA | NA | 0 | 0 | NA |
Convertible Debt | NA | NA | 0 | 0 | NA |
Long-Term Debt | NA | 36 | 36 | 35 | 35 |
Non-Current Capital Leases | NA | 3 | 4 | 3 | 3 |
Other Non-Current Liabilities | NA | 63 | 60 | 36 | |
Minority Interest (Liabilities) | NA | NA | 0 | 0 | NA |
Total Liabilities | NA | 123 | 122 | 118 | 116 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | 0 | 0 | NA |
Common Stock (Par) | NA | 174 | 174 | 173 | 173 |
Capital Surplus | NA | 153 | 153 | 153 | 153 |
Retained Earnings | NA | -340 | -331 | -320 | -311 |
Other Equity | NA | 12 | 12 | 11 | 11 |
Treasury Stock | NA | NA | 0 | 0 | NA |
Total Shareholder's Equity | NA | -1 | 7 | 18 | 27 |
Total Liabilities & Shareholder's Equity | NA | 122 | 129 | 136 | 143 |
Total Common Equity | 0 | 99,998 | 7 | 18 | 100,026 |
Shares Outstanding | NA | NA | 1.50 | 1.50 | 1.50 |
Book Value Per Share | 0.00 | -1.00 | 4.81 | 11.89 | 66,683.77 |